Pfizer May Have the Edge Over Moderna In Vaccine Race
Sam Fazeli, Director of Research: EMEA at Bloomberg Intelligence, on the race for a covid vaccine. Brendan Ahern, Chief Investment Officer at KraneShares, on why U.S.-listed Chinese companies are re-l...
21 Heinä 202026min
The Impact of COVID-19 on Business Travel
Katie Nixon, CIO of Northern Trust Wealth Management, discusses markets and her current investment outlook. Bloomberg News Industrial, Aerospace and Chemicals Team Leader Brendan Case talks about U.S....
20 Heinä 202028min
Gen-Z Is Looking To Juice Gains With Stocks, Options Trading
Eric Balchunas, Senior ETF Analyst for Bloomberg Intelligence, on Gen-Z's adoption of volatility in stock trading. Laura Davison, Bloomberg Congressional tax reporter, on U.S. virus relief set to vani...
17 Heinä 202028min
Vaccine Is 'Strategic Asset' That Hackers Will Target: Clint Watts
Clint Watts, Distinguished Research Fellow at the Foreign Policy Research Institute and former FBI agent, on the massive Twitter hack, and hackers trying to steal UK vaccine research. Barry Ritholtz, ...
16 Heinä 202029min
America's $2 Trillion Rescue Leaves Black Neighborhoods Behind
Shawn Donnan, Senior Trade and Globalization reporter for Bloomberg, to discuss his story: A $2 Trillion Rescue Leaves America’s Black Neighborhoods Behind. Ellen Wald, President of Transversal Consul...
16 Heinä 202028min
The Real Problem Facing Sports Is Weakened Sponsorship
Sports veteran Neal Pilson, founder and president of Pilson Communications, and former President of CBS Sports, on the outlook for sports programming and advertising, as the sports shutdown takes a to...
14 Heinä 202026min
Why Homebuilder Taylor Morrison Just Had Its Best Month Ever
Sheryl Palmer, Chairman and CEO of homebuilder Taylor Morrison, discusses why they just had their best month in company history. Jim Vogel, Executive VP and Interest Rate Strategist for FHN Financial,...
13 Heinä 202027min
Remdesivir Needs More Trials Before Going All In: MMKCC's Bach
Dr. Peter Bach, Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes, on his column: "Hospitals Need to Study How Well Remdesivir Works." Alan Crawford, Senior International Go...
13 Heinä 202029min
